HOME >> MEDICINE >> NEWS
Study shows that anal cytology predicts anal precancer in HIV-positive gay men

FINDINGS: HIV-positive men who have sex with men are up to 90 times more likely than the general population to develop anal cancer. Detection of precancerous changes (anal dysplasia) by anal cytology essentially an anal canal Pap smear is a relatively new procedure and one that has yet to enter standard practice.

This UCLA study demonstrated that abnormal anal cytology was highly predictive of anal cell abnormalities that were subsequently confirmed by anal biopsy. The study was based on data from 244 patients at the UCLA CARE clinic who had anal cytology screenings between February 2002 and December 2004.

IMPACT: Abnormal anal cytology in HIV-positive men who have sex with men is highly indicative of the presence of abnormal anal cells that may be precancerous and should prompt further investigation. The UCLA CARE Center is one of a handful of clinics in the United States offering an anal dysplasia screening and management service.

AUTHORS: Ross D. Cranston, Steven.D. Hart , Jeffrey A. Gornbein, Sharon L. Hirschowitz, Galen Cortina, and Ardis.A. Moe, all of UCLA.

JOURNAL: The research appears in the February issue of the International Journal of STD & AIDS.


'"/>

Contact: Enrique Rivero
erivero@mednet.ucla.edu
310-794-2273
University of California - Los Angeles
21-Mar-2007


Page: 1

Related medicine news :

1. Study, meta-analysis examine factors associated with death from heatstroke
2. Study says COPD testing is not measuring up
3. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
4. Study reveals gaps in vaccine financing for underinsured children
5. Study suggests nonpharmaceutical interventions may be helpful in severe influenza outbreaks
6. Study shows radiofrequency ablation highly effective in treating kidney tumors
7. Study says normal but out-of-control enzyme may be culprit that signals some cells to become cancer
8. Study finds HIV protease inhibitor drugs may adversely affect the scaffolding of the cell nucleus
9. Study outlines how stroke, head injury can increase risk of Alzheimers disease
10. Study identifies new regulator of fat metabolism
11. Study shows Diachrome improves blood sugar control in people with type 2 diabetes

Post Your Comments:
(Date:5/23/2013)... May 23, 2013 Better Life Maids of ... it prepares to launch its one of a kind green ... management staff will be completed May 29th, and a soft ... Richardson completed on site training in Portland recently and will ... complete operational training. , "It really is a lot to ...
(Date:5/23/2013)... PhD Box has introduced a ... the research process by offering assistance for Thesis Proposals. The ... of services that the company provides for research consultation in ... dedicated proposal writing service is that this is the stage ... research process find it difficult to draft a proposal as ...
(Date:5/23/2013)... 2013 Footwear etc. is pleased to announce ... of sandals containing cork footbeds. Known for its extremely supportive ... sales for many years, and with this new collection is ... , Dansko Shoes and Sandals are renowned for ... no exception. Containing leather and patent leather uppers in metallic ...
(Date:5/23/2013)... Following the recent outbreak of fake ... the security team at idcloak Technologies has identified a ... or any web-born malware. Gill-Chris Welles of the ... better privacy and security than traditional antivirus ... the best AV software cannot be depended on: it ...
(Date:5/23/2013)... 23, 2013 Long-Term Care Insurance ... the rate at which applicants for Long Term Care Insurance ... , The decision to buy a Long Term ... consumers willing and able to purchase protection are increasingly being ... at any price. A variety of chronic conditions appear ...
Breaking Medicine News(10 mins):Health News:Better Life Maids of Portland Oregon Prepares For a Summer of 2013 Launch 2Health News:PhD Box Unveils Proposal Writing Services for Research Scholars 2Health News:Footwear etc. Announces the New Collection of Dansko Cork Sandals 2Health News:Effective virus protection without anti-virus software, identifies idcloak 2Health News:More Baby Boomers Rejected by Long Term Care Insurance Companies 2Health News:More Baby Boomers Rejected by Long Term Care Insurance Companies 3
(Date:5/22/2013)... , May 22, 2013 Pomerantz ... investigating claims on behalf of investors of Intuitive Surgical, ... ISRG ) (CUSIP: 46120E602) who purchased Intuitive Surgical common ... (the "Class Period"). Such investors are advised to contact ... rswilloughby@pomlaw.com or 888-476-6529, ext. 237. The ...
(Date:5/22/2013)... Minn. , May 22, 2013 /PRNewswire/ ... the successful completion of its global Phase ... an internally developed program for the management ... proprietary formulation technology.  USL255 is specifically engineered ... fluctuations in topiramate blood levels observed with ...
(Date:5/22/2013)... Mass. and TORONTO , ... ) (OTCBB: GNBT) today announced three presentations demonstrating the ... by its wholly-owned subsidiary, Antigen Express, Inc. ( www.antigenexpress.com ... meeting of the American Society of Clinical Oncology (ASCO) ... from May 31 through June 4, 2013. ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intuitive Surgical, Inc. - ISRG 2Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 2Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 3Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 4Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 2Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 3Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 4
Cached News: